XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
XS-03 in combination with FOLFOX or FOLFIRI and Bevacizumab for treatment of metastatic colorectal cancer patients with RAS mutation
Epistemonikos ID: 21d419688fea26b35ac9a103e32a488260428fb5
First added on: Apr 22, 2025